跳至主要内容
临床试验/NCT00798278
NCT00798278已完成3 期

Exploratory Multicentre Clinical Trial to Compare the Efficacy of Urokinase Versus Video-assisted Thoracoscopic for Treatment of Complicated Parapneumonic Empyema in Childhood

Spanish Society of Pediatric Surgery6 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200
试验地点
6
主要终点
duration of the hospital stay after the treatment

研究概览

简要总结

A great controversy exists about which is the best method to perform the evacuation of the collection. The purpose of this study is to evaluate which is the best initial treatment to drain complicated parapneumonic empyema (stages II and III) in children: the present study raises a hypothesis of equivalence between both arms of treatment (chest drainage plus intrapleural urokinase or videothoracoscopic debridement).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients less than 15 years of age with pneumonia and persistent fever, and complicated parapneumonic empyema (septation or loculation seen on ultrasound or Rx thorax)stages II and III requiring an intervention to drain

排除标准

  • Existing contraindications or other previous conditions, hypertension, pneumothorax

研究组 & 干预措施

Urokinase

Experimental

urokinase infusion for 3 days

干预措施: Urokinase (Drug)

Thoracoscopic

Active Comparator

Video-Assisted Thoracoscopic

干预措施: Video-Assisted Thoracoscopic (Procedure)

结局指标

主要结局

duration of the hospital stay after the treatment

时间窗: 3 months

次要结局

  • complications of the treatment and complications of the disease(3 months)
  • total duration of the hospital stay(3 months)
  • number of days carrying the chest drain(3 months)
  • duration of the fever once the empyema has been drained(3 months)

研究者

发起方
Spanish Society of Pediatric Surgery
申办方类型
Other

研究点 (6)

Loading locations...

相似试验